Persistence of Cryoglobulinemic Vasculitis after DAA Induced HCV Cure

Persistence of Cryoglobulinemic Vasculitis after DAA Induced HCV Cure

Treatment with a direct acting antiviral (DAA) has revolutionized HCV therapy, as more than 95% of patients achieve a sustained virological response (SVR). Cryoglobulinemic vasculitis (CryoVas), however, can persist and recur after the HCV cure. In this systematic review, we include data from 19 stu...

Full description

Bibliographic Details
Main Authors: Mahmood Danishwar, Zahid Jamil, Salman Khan, Michael Nakhla, Ishtiaq Ahmad, Muhammad Ashar Ali, Daryl T. Y. Lau
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Journal of Clinical Medicine
Subjects:
cryoglobulinemic vasculitis
DAA therapy
cryoglobulinemia
hepatitis C
Online Access:https://www.mdpi.com/2077-0383/11/4/984

Similar Items

Similar Items